226 related articles for article (PubMed ID: 8914458)
1. [All-trans retinoic acid therapy in acute promyelocytic leukemia--current status and prospect].
Kitamura K; Takeshita A; Ono R; Naoe T
Rinsho Ketsueki; 1996 Sep; 37(9):760-5. PubMed ID: 8914458
[No Abstract] [Full Text] [Related]
2. [Role of retinoic acid in the treatment of acute promyelocytic leukemia].
Gutiérrez de Guzmán J; Kantarjian H
Sangre (Barc); 1993 Oct; 38(5):375-8. PubMed ID: 8140499
[No Abstract] [Full Text] [Related]
3. Molecular pathology of acute promyelocytic leukemia.
Chang KS
Hematol Pathol; 1993; 7(4):209-23. PubMed ID: 8113150
[No Abstract] [Full Text] [Related]
4. [Arsenic and retinoic acid, toward targeted treatments of acute promyelocytic anemia?].
de Thé H
C R Seances Soc Biol Fil; 1998; 192(2):273-81. PubMed ID: 9759370
[TBL] [Abstract][Full Text] [Related]
5. FISH-negative, cytogenetically cryptic acute promyelocytic leukemia.
Rashidi A; Fisher SI
Blood Cancer J; 2015 Jun; 5(6):e320. PubMed ID: 26090620
[No Abstract] [Full Text] [Related]
6. Genetics of APL and the molecular basis of retinoic acid treatment.
Casini T; Grignani F; Pelicci PG
Int J Cancer; 1997 Feb; 70(4):473-4. PubMed ID: 9033658
[No Abstract] [Full Text] [Related]
7. Retinoic acid regulatory pathways, chromosomal translocations, and acute promyelocytic leukemia.
Chen Z; Tong JH; Dong S; Zhu J; Wang ZY; Chen SJ
Genes Chromosomes Cancer; 1996 Mar; 15(3):147-56. PubMed ID: 8721678
[TBL] [Abstract][Full Text] [Related]
8. Acute promyelocytic leukemia: from genetics to treatment.
Grignani F; Fagioli M; Alcalay M; Longo L; Pandolfi PP; Donti E; Biondi A; Lo Coco F; Grignani F; Pelicci PG
Blood; 1994 Jan; 83(1):10-25. PubMed ID: 8274729
[No Abstract] [Full Text] [Related]
9. All-trans-retinoic acid in acute promyelocytic leukemia.
Sanz MA; Martín G; Díaz-Mediavilla J
N Engl J Med; 1998 Feb; 338(6):393-4. PubMed ID: 9454087
[No Abstract] [Full Text] [Related]
10. All-trans retinoic acid and arsenic trioxide resistance of acute promyelocytic leukemia with the variant STAT5B-RARA fusion gene.
Strehl S; König M; Boztug H; Cooper BW; Suzukawa K; Zhang SJ; Chen HY; Attarbaschi A; Dworzak MN
Leukemia; 2013 Jul; 27(7):1606-10. PubMed ID: 23271512
[No Abstract] [Full Text] [Related]
11. Mutations of the PML tumor suppressor gene in acute promyelocytic leukemia.
Gurrieri C; Nafa K; Merghoub T; Bernardi R; Capodieci P; Biondi A; Nimer S; Douer D; Cordon-Cardo C; Gallagher R; Pandolfi PP
Blood; 2004 Mar; 103(6):2358-62. PubMed ID: 14630830
[TBL] [Abstract][Full Text] [Related]
12. Differentiation therapy of acute promyelocytic leukemia: clinical and molecular features.
Miller WH
Cancer Invest; 1996; 14(2):142-50. PubMed ID: 8597899
[No Abstract] [Full Text] [Related]
13. Distinct interactions of PML-RARalpha and PLZF-RARalpha with co-repressors determine differential responses to RA in APL.
He LZ; Guidez F; Tribioli C; Peruzzi D; Ruthardt M; Zelent A; Pandolfi PP
Nat Genet; 1998 Feb; 18(2):126-35. PubMed ID: 9462740
[TBL] [Abstract][Full Text] [Related]
14. Acute promyelocytic leukaemia and the t(15;17) translocation.
Gillard EF; Solomon E
Semin Cancer Biol; 1993 Dec; 4(6):359-67. PubMed ID: 8142621
[TBL] [Abstract][Full Text] [Related]
15. Diagnosis, front line treatment and molecular monitoring of acute promyelocytic leukaemia.
Lo Coco F; Diverio D; Avvisati G; Mandelli F
Haematologica; 1999 Jun; 84 Suppl EHA-4():72-4. PubMed ID: 10907474
[No Abstract] [Full Text] [Related]
16. Do RARA/PML fusion gene deletions confer resistance to ATRA-based therapy in patients with acute promyelocytic leukemia?
Subramaniyam S; Nandula SV; Nichols G; Weiner M; Satwani P; Alobeid B; Bhagat G; Murty VV
Leukemia; 2006 Dec; 20(12):2193-5. PubMed ID: 17008891
[No Abstract] [Full Text] [Related]
17. Delayed or insufficient restoration of PML and PML-RAR alpha subcellular localization after exposure in vitro to retinoic acids in all-trans retinoic acid-resistant APL cells.
Naoe T; Yoshida H; Kitamura K; Chino M; Osumi K; Ohno R
Leukemia; 1995 Sep; 9(9):1610-1. PubMed ID: 7658735
[No Abstract] [Full Text] [Related]
18. Identification of a novel PML-RARG fusion in acute promyelocytic leukemia.
Ha JS; Do YR; Ki CS; Lee C; Kim DH; Lee W; Ryoo NH; Jeon DS
Leukemia; 2017 Sep; 31(9):1992-1995. PubMed ID: 28555082
[No Abstract] [Full Text] [Related]
19. Understanding the molecular pathogenesis of acute promyelocytic leukemia.
Lo-Coco F; Hasan SK
Best Pract Res Clin Haematol; 2014 Mar; 27(1):3-9. PubMed ID: 24907012
[TBL] [Abstract][Full Text] [Related]
20. IRF2BP2-RARA t(1;17)(q42.3;q21.2) APL blasts differentiate in response to all-trans retinoic acid.
Mazharuddin S; Chattopadhyay A; Levy MY; Redner RL
Leuk Lymphoma; 2018 Sep; 59(9):2246-2249. PubMed ID: 29350080
[No Abstract] [Full Text] [Related]
[Next] [New Search]
